文献速递间质性肺疾病

特发性胸膜肺实质弹力纤维增生症:三维CT评估上叶肺容积

Idiopathic pleuroparenchymal fibroelastosis: three-dimensional computed tomography assessment of upper-lobe lung volume.
PubMed 文献 · Eur Respir J · 2022-12-22

本研究回顾性分析两个队列共132例iPPFE患者及45例对照,用三维CT定量测量各肺叶容积并以预测用力肺活量标准化。结果显示iPPFE患者标准化上叶容积不足对照的一半,低上叶容积与更短生存率及更高死亡风险独立相关,包含年龄、性别和标准化上叶容积的复合评分模型对死亡风险的预测优于GAP模型。

要点

  • iPPFE患者标准化上叶容积不足对照的一半,下叶容积未见下降。
  • 低标准化上叶容积者中位生存6.08年 vs 2.48年(p<0.001)。
  • 复合评分模型(年龄、性别、标准化上叶容积)预测死亡风险优于GAP模型。

核心结论

  • 评估上叶容积可为iPPFE临床管理提供疾病严重程度和死亡风险的有用信息。

研究设计与样本

  • 回顾性研究,纳入两个队列共132例iPPFE患者(Hamamatsu队列69例,Seirei队列63例)和45例对照。
  • 在iPPFE诊断时用三维计算机断层扫描定量测量各肺叶容积,并以预测用力肺活量标准化。

主要发现

  • iPPFE患者标准化上叶容积小于对照的一半,而下叶容积未下降。
  • 标准化上叶容积较低的iPPFE患者生存率显著短于较高者(中位生存6.08年 vs 2.48年,p<0.001)。
  • 多变量分析中,校正年龄、性别和用力肺活量后,较低标准化上叶容积与死亡风险增加显著相关(HR 0.939)。
  • 包含年龄、性别和标准化上叶容积的复合评分模型对死亡风险的预测优于性别-年龄-生理学(GAP)模型。

临床怎么用

  • 临床可用三维CT定量评估iPPFE患者上叶容积,辅助判断疾病严重程度和死亡风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Idiopathic pleuroparenchymal fibroelastosis (iPPFE) is a rare interstitial lung disease characterised by predominant upper-lobe fibrosis involving the pleura and subpleural lung parenchyma. Despite its poor prognosis, there is no consensus on prognostic determinants of iPPFE to date. Because volume loss in the upper lobe is a distinct feature of iPPFE, we hypothesised that the lung volume of the bilateral upper lobes (upper-lobe volume) accurately indicates disease severity and mortality risk in iPPFE patients. METHODS: This retrospective study assessed two cohorts of 132 patients with iPPFE (69 in Hamamatsu cohort; 63 in Seirei cohort) and 45 controls. Each lobe volume was quantitatively measured using three-dimensional computed tomography at the time of iPPFE diagnosis and standardised using predicted forced vital capacity. RESULTS: The standardised upper-lobe volume in iPPFE patients was less than half that of controls, whereas the lower-lobe volume did not decrease. iPPFE patients with lower standardised upper-lobe volume had significantly shorter survival rates than those with higher volume (median survival: 6.08 versus 2.48 years, p<0.001). In multivariate analysis, the lower standardised upper-lobe volume was significantly associated with increased mortality adjusting for age, sex and forced vital capacity (HR 0.939). A composite scoring model, including age, sex and standardised upper-lobe volume, better predicted risk of death than the gender-age-physiology model. CONCLUSION: Assessment of upper-lobe volume provides useful information for managing iPPFE by evaluating disease severity and mortality risk in clinical practice.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Fukada A, Suzuki Y, Mori K, et al. Idiopathic pleuroparenchymal fibroelastosis: three-dimensional computed tomography assessment of upper-lobe lung volume. Eur Respir J. 2022. PMID: 35798359. doi:10.1183/13993003.00637-2022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。